BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 7773579)

  • 1. Management of cancer anorexia/cachexia.
    Loprinzi CL
    Support Care Cancer; 1995 Mar; 3(2):120-2. PubMed ID: 7773579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia.
    Loprinzi CL; Ellison NM; Schaid DJ; Krook JE; Athmann LM; Dose AM; Mailliard JA; Johnson PS; Ebbert LP; Geeraerts LH
    J Natl Cancer Inst; 1990 Jul; 82(13):1127-32. PubMed ID: 2193166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.
    Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ
    J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a treatment for anorexia and cachexia in patients with cancer.
    Thirlby RC
    Gastroenterology; 1991 Jul; 101(1):268-70. PubMed ID: 2044918
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of anorexia with megestrol acetate.
    Tchekmedyian NS
    Nutr Clin Pract; 1993 Jun; 8(3):115-8. PubMed ID: 8289758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megestrol acetate for anorexia and cachexia.
    Loprinzi CL; Johnson PA; Jensen M
    Oncology; 1992; 49 Suppl 2():46-9. PubMed ID: 1461628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia.
    Von Roenn JH
    Oncology; 1994 Oct; 51 Suppl 1():19-24. PubMed ID: 7970504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection.
    Von Roenn JH; Murphy RL; Wegener N
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):13-6. PubMed ID: 2259923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
    Loprinzi CL; Michalak JC; Schaid DJ; Mailliard JA; Athmann LM; Goldberg RM; Tschetter LK; Hatfield AK; Morton RF
    J Clin Oncol; 1993 Apr; 11(4):762-7. PubMed ID: 8478668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
    Loprinzi CL; Ellison NM; Goldberg RM; Michalak JC; Burch PA
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):8-12. PubMed ID: 2259930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megestrol acetate for the treatment of anorexia-cachexia syndrome.
    Berenstein EG; Ortiz Z
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management of anorexia and cachexia in patients with advanced cancer.
    Bruera E
    Oncology; 1992; 49 Suppl 2():35-42. PubMed ID: 1461626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated anorexia and cachexia. Implications for drug therapy.
    Loprinzi CL; Goldberg RM; Burnham NL
    Drugs; 1992 Apr; 43(4):499-506. PubMed ID: 1377116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study.
    Feliu J; González-Barón M; Berrocal A; Artal A; Ordóñez A; Garrido P; Zamora P; García de Paredes ML; Montero JM
    Am J Clin Oncol; 1992 Oct; 15(5):436-40. PubMed ID: 1524045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megestrol acetate for treatment of anorexia-cachexia syndrome.
    Ruiz Garcia V; López-Briz E; Carbonell Sanchis R; Gonzalvez Perales JL; Bort-Marti S
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD004310. PubMed ID: 23543530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
    Gebbia V; Testa A; Gebbia N
    Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose megestrol acetate for appetite stimulation in advanced cancer.
    Donnelly S; Walsh TD
    J Pain Symptom Manage; 1995 Apr; 10(3):182-3. PubMed ID: 7629410
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia.
    Vadell C; Seguí MA; Giménez-Arnau JM; Morales S; Cirera L; Bestit I; Batiste E; Blanco R; Jolis L; Boleda M; Antón I
    Am J Clin Oncol; 1998 Aug; 21(4):347-51. PubMed ID: 9708631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body-composition changes in patients who gain weight while receiving megestrol acetate.
    Loprinzi CL; Schaid DJ; Dose AM; Burnham NL; Jensen MD
    J Clin Oncol; 1993 Jan; 11(1):152-4. PubMed ID: 8418227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appetite stimulation and weight gain with megestrol acetate.
    Aisner J; Parnes H; Tait N; Hickman M; Forrest A; Greco FA; Tchekmedyian NS
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):2-7. PubMed ID: 2259925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.